Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
45
MAZE Quote, Financials, Valuation and Earnings
Last price:
$42.07
Seasonality move
:
--
Day range:
$41.46 - $42.92
52-week range:
$6.71 - $43.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
501.13x
P/B ratio:
5.34x
Volume:
92.1K
Avg. volume:
477.7K
1-year change:
--
Market cap:
$2B
Revenue:
$167.5M
EPS (TTM):
-$2.25
Earnings Data
Next earnings date for MAZE
Mar 05
2026
Most recent earnings per share
-$0.63
Beat by $0.07
(Nov 6/2025)
Consensus Estimate
-$0.69
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MAZE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | -- | -- | -- | -$0.67 | -- |
| 11/06/2025 | Q3 | -- | -- | -$0.63 | -$0.69 | $0.07 |
| 08/12/2025 | Q2 | $2.1M | -- | -$0.77 | -$1.16 | $0.39 |
| 05/14/2025 | Q1 | -- | -- | -$0.75 | -$0.63 | -$0.12 |
| 03/31/2025 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2024 | Q3 | -- | $2.5M | -$0.06 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.74 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.61 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.57 | -- | -- |
Maze Therapeutics, Inc. Earnings Questions
-
How Much did Maze Therapeutics, Inc. Generate in Revenue Last Quarter?
Maze Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Maze Therapeutics, Inc. Beat Earnings Last Quarter?
Maze Therapeutics, Inc. announced earnings per share of -$0.63 which represents a beat of analyst forecast a -$0.69 per share.
-
Is Maze Therapeutics, Inc. Profitable?
Maze Therapeutics, Inc. reported -$571K that represents -$0.01 per share over the last quarter.
-
What is the Analyst Consensus for Maze Therapeutics, Inc. EPS Next Year?
Maze Therapeutics, Inc.'s earnings are forecast to decrease from $0.08 per share to -$20.10 per share next year representing a decrease of -776.18%.
-
When is Maze Therapeutics, Inc.'s Earnings Date?
Maze Therapeutics, Inc.'s next earnings date is March 5, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
